Basic requirements for marketing homeopathic OTC drugs
Legal definitions of cosmetics, drugs and dietary supplements
Regulation differences in allopathic (conventional) drugs and homeopathic drugs
Formulation and label of cosmeceuticals products
Recent FDA Public Hearings aimed at changing the current FDA OTC Monograph System
Minimize the regulatory risk of a Warning Letter or other FDA action
Who should Attend
Product Managers
Senior Managers / Business Owners
Regulatory and Quality Professionals
Labeling and Artwork Designers
R&D Managers and Staff
Sales and Marketing Managers
Past Events
Manufacturing and Marketing OTC Drugs in Compliance with FDA Regulations (Updated to address recent Homeopathic Drug announcements by FDA & FTC) 2018 - 2018, United States (67246)
Manufacturing and Marketing OTC Drugs in Compliance with FDA Regulations (Updated to address recent Homeopathic Drug announcements by FDA & FTC) 2017 - 07-08 Nov 2017, San Francisco, California, United States (67245)
Manufacturing and Marketing OTC Drugs in Compliance with FDA Regulations (Updated to address recent Homeopathic Drug announcements by FDA & FTC) 2016 - 02-03 Aug 2016, San Francisco, California, United States (54013)
Manufacturing and Marketing OTC Drugs in Compliance with FDA Regulations (Updated to address recent Homeopathic Drug announcements by FDA & FTC) 2026
Important
Please, check "Manufacturing and Marketing OTC Drugs in Compliance with FDA Regulations (Updated to address recent Homeopathic Drug announcements by FDA & FTC)" official website for possible changes, before making any traveling arrangements
